FULL PAPER
General Procedure for the Preparation of Carboranes 2: 6,9-
(Me2S)2-B10H12 (147 mg, 0.6 mmol) and the corresponding alkyne
(0.4 mmol) were placed into a round-bottomed flask equipped with
a condenser and an argon inlet. Toluene (4 mL) was added, and
the reaction mixture was heated in an oil bath at 120 °C under
argon for 16 h. After cooling, methanol (2 mL) was added to the
reaction mixture, and the volatiles were removed under reduced
pressure. The residue was purified by column chromatography on
silica gel to afford the product by using chloroform or dichloro-
methane/hexane mixtures as the eluent. Particular synthetic details
and characterization data are given below.
1-Ferrocenyl-2-[4-(methoxycarbonyl)phenyl]-1,2-dicarba-closo-dode-
caborane (2d): {[4-(Methoxycarbonyl)phenyl]ethynyl}ferrocene
(69 mg, 0.2 mmol), 6,9-(Me2S)2-B10H12 (64 mg, 0.26 mmol). Col-
umn chromatography (2:1 hexane/CHCl3) yielded 56 mg (61%) of
the title compound as an orange solid, m.p. 162–164 °C (CHCl3).
1H{11B} NMR (400 MHz, C6D6): δ = 7.66 (d, J = 8.5 Hz, 2 H, H–
Ar), 7.22 (d, J = 8.6 Hz, 2 H, Ar–H), 3.91 (s, 5 H, Fc), 3.89–3.86
(m, 2 H, Fc), 3.52–3.47 (m, 2 H, Fc), 3.33 (s, 4 H, CH3 and 12-H),
3.16 (br. s, 1 H, B9–H), 3.06 [br. s, 2 H, B(3,6)–H], 2.96 [br. s, 2
H, B(8,10)–H], 2.86 [br. s, 2 H, B (7,11)–H], 2.72 [br. s, 2 H, B(4,5)–
H] ppm. 13C NMR (151 MHz, C6D6): δ = 165.79 (C=O), 135.79
(C–Ar), 132.36 (C–Ar), 131.58 (C–Ar), 129.74 (C–Ar), 128.68 (C–
Ar), 86.16 (C–carborane), 85.01 (C–carborane), 83.37 (Fc), 71.72
(Fc), 71.09 (Fc), 69.23 (Fc), 52.06 (CH3) ppm. 11B NMR
(128 MHz, C6D6, BF3·OEt2): δ = –0.54 (d, JB,H = 152 Hz, 1 B,
B12), –1.83 (d, JB,H = 131 Hz, 1 B, B9), –7.91 [d, JB,H = 130 Hz, 4
B, B(8,10; 7,11)], –9.84 [d, JB,H = 115 Hz, 4 B, B(3,6; 4,5)] ppm.
HRMS (EI) calcd. for C20H2610B211B8O2Fe: 462.2285; found
462.2286. MS (EI): m/z (%) = 462.2 (100) [M+], 279.2 (10), 216.1
(20), 121.0 (20). C20H26B10FeO2 (464.22): calcd. C 51.95, H 5.67,
1-Ferrocenyl-1,2-dicarba-closo-dodecaborane (2a): Ethynylferrocene
(105 mg, 0.50 mmol), 6,9-(Me2S)2-B10H12 (183 mg, 0.75 mmol).
Column chromatography (6:1 hexane/CH2Cl2) yielded 43 mg
(26%) of 2a as an orange solid. Spectral characteristics were in
agreement with the published data,[11b] m.p. 121–123 °C (CHCl3).
1H NMR (600 MHz, C6D6): δ = 3.92 (apt, J = 2.0 Hz, 2 H, Fc),
3.87 (s, 5 H, Fc), 3.70 (apt, J = 2.0 Hz, 2 H, Fc), 2.86 (s, 1 H, CH)
ppm. 13C NMR (150 MHz, C6D6): δ = 65.3 (C–carborane), 69.0
(Fc), 70.5 (Fc), 70.6 (Fc), 76.5 (Fc), 86.4 (C–carborane) ppm.
Fe 12.08; found C 51.68, H 5.69, Fe 11.39. IR (KBr): ν = 2591,
˜
1-Ferrocenyl-2-methyl-1,2-dicarba-closo-dodecaborane (2b): (Pro-
pyn-1-yl)ferrocene, (90 mg, 0.40 mmol), 6,9-(Me2S)2-B10H12
(146 mg, 0.60 mmol). Column chromatography (10:1 hexane/
CH2Cl2) yielded 29 mg (21%) of the title compound as an orange
solid. Spectral characteristics were in agreement with the published
2573, 2552, 1724, 1434, 1287, 1123, 836 cm–1. Rf (2:1 hexane/
CHCl3) = 0.5.
1,2-Diferrocenyl-1,2-closo-dicarbadodecaborane (2e): Diferrocenyl-
ethyne (39 mg, 0.1 mmol), 6,9-(Me2S)2-B10H12 (37 mg, 0.15 mmol).
Column chromatography (4:1 hexane/CHCl3) yielded 30 mg (58%)
of the title compound as a red solid, m.p. 259–261 °C (CHCl3).
1H{11B} NMR (400 MHz, C6D6): δ = 3.97–3.90 (m, 14 H, Fc),
3.64–3.58 (m, 4 H, Fc), 3.36 [br. s, 2 H, B(9,12)–H], 3.13 [br. s, 4
H, B(3,6; 4,5)–H], 2.89 [br. s, 4 H, B(7,11; 8,10)–H] ppm. 13C
NMR (151 MHz, C6D6): δ = 86.04 (C–carborane), 83.64 (Fc),
72.08 (Fc), 71.02 (Fc), 68.88 (Fc) ppm. 11B NMR (128 MHz, C6D6,
BF3·OEt2): δ = –1.81 [d, J = 114 Hz, 2 B, B(9,12)], –7.95 [d, J =
106 Hz, 6 B, B(3,6; 4,5; 7,11)], –11.11 [d, J = 125 Hz, 2 B, B(8,10)]
ppm. HRMS (EI) calcd. for C22H2810B211B8Fe2: 512.1893; found
512.1887. MS (EI): m/z (%) = 512.2 (100) [M+], 447.2 (10), 256.1
(20), 121.2 (80). C22H28B10Fe2 (514.18): calcd. C 51.58, H 5.51;
1
data,[21] m.p. 127 °C (CHCl3). H{11B} NMR (400 MHz, C6D6): δ
= 4.02 [apt, JH,H = 2.0 Hz, 2 H, Fc], 3.98 (s, 5 H, Fc), 3.76 (apt,
JH,H = 2.0 Hz, 2 H, Fc), 3.11 (br. s, 1 H, B12–H), 3.00 (br. s, 1 H,
B9–H), 2.93 [br. s, 2 H, B(8,10)–H], 2.73 [br. s, 2 H, B(3,6)–H],
2.50 [s, 2 H, B(5,4)-H], 2.36 [s, 2 H, B(7,11)–H], 1.04 (s, 3 H, CH3)
ppm. 13C NMR (75 MHz, C6D6): δ = 84.3 (C–carborane), 82.1 (C–
carborane), 78.0 (Fc), 72.0 (Fc), 71.6 (Fc), 69.7 (Fc), 23.0 (CH3)
ppm. 11B NMR (128 MHz, C6D6, BF3·OEt2): δ = –4.80 [d, JB,H
=
155 Hz, 2 B, B(9,12)], –9.97 [d, JB,H = 165 Hz, 6 B, B(4,5; 7,11;
8,10)], –11.85 [d, JB,H = 152 Hz, 2 B, B(3,6)] ppm. HRMS calcd.
for C13H2210B211B8Fe: 342.2069; found 342.2069. MS (ESI): m/z
(%) = 342 (100) [M+], 256 (7), 228 (27). C13H22B10Fe (344.20):
calcd. C 45.62, H 6.48, Fe 16.32; found C 45.68, H 6.27, Fe 16.03.
found C 51.45, H 5.29. IR (KBr): ν = 2663, 2603, 2576, 1443, 1269,
˜
1108, 821 cm–1. Rf (4:1 hexane/CHCl3) = 0.6.
IR (KBr): ν = 2624, 2596, 2575, 2563, 1106, 1135, 829 cm–1. R
˜
f
(10:1 hexane/CH2Cl2) = 0.3.
1-Ferrocenyl-2-(ferrocenylethyn-1-yl)-1,2-dicarba-closo-dodecabor-
ane (2f): 1,4-Diferrocenyl-1,3-butadiyne (84 mg, 0.2 mmol), 6,9-
(Me2S)2-B10H12 (59 mg, 0.24 mmol). Column chromatography (5:1
hexane/CH2Cl2) yielded 56 mg (52%) of the title compound as an
orange solid, m.p. 211 °C (benzene/chloroform). 1H {11B} NMR
(400 MHz; C6D6): δ = 4.44 (apt, JH,H = 2.0 Hz, 2 H, Fc), 4.08 (apt,
JH,H = 2.0 Hz, 2 H, Fc), 4.00 (s, 5 H, Fc), 3.92 (s, 5 H, Fc), 3.88
(apt, JH,H = 2.0 Hz, 2 H, Fc), 3.76 (apt, JH,H = 2.0 Hz, 2 H, Fc),
3.20 (br. s, 1 H, B12–H), 3.03 (br. s, 1 H, B9–H), 3.01 [br. s, 6 H,
B(4,5; 7,11; 8,10)–H], 2.83 [br. s, 2 H, B(3,6)–H] ppm. 13C NMR
(75 MHz, C6D6): δ = 86.8 (C–carborane), 84.8 (C–carborane), 84.1
(Fc), 80.1 (Fc), 72.8 (Fc), 72.7 (Fc), 72.5 (C–alkyne), 71.5 (Fc),
71.0 (Fc), 70.3 (Fc), 69.8 (Fc), 62.4 (C–alkyne) ppm. 11B NMR
(128 MHz, C6D6, BF3·OEt2): δ = –1.71 (d, JB,H = 151 Hz, 1 B,
B12), –4.11 (d, JB,H = 151 Hz, 1 B, B9), –9.13 [d, JB,H = 143 Hz, 6
B, B(4,5; 8, 0; 7,11)], –10.28 [d, JB,H = 150 Hz, 2 B, B(3,6)] ppm.
HRMS calcd. for C24H2810B211B8Fe2: 536.1893; found 536.1894.
MS (EI): m/z (%) = 536 (47) [M+], 268 (8), 186 (21), 121 (44), 84
(100). C24H28B10Fe2 (538.18): calcd. C 53.75, H 5.26, Fe 20.83;
1-Ferrocenyl-2-phenyl-1,2-dicarba-closo-dodecaborane (2c): (2-Phen-
ylethynyl)ferrocene (100 mg, 0.35 mmol), 6,9-(Me2S)2-B10H12
(128 mg, 0.53 mmol). Column chromatography (2:1 hexane/CHCl3)
yielded 85 mg (60%) of the title compound as an orange solid, m.p.
171–174 °C (CHCl3). 1H{11B} NMR (400 MHz, C6D6): δ = 7.23
(d, JH,H = 7.7 Hz, 2 H, Ar–H), 6.77 (t, JH,H = 7.4 Hz, 1 H, Ar–
H), 6.70 (t, JH,H = 7.8 Hz, 2 H, Ar–H), 3.93 (s, 5 H, Fc), 3.91 (t,
JH,H = 1.9 Hz, 2 H, Fc), 3.51 (t, JH,H = 1.8 Hz, 2 H, Fc), 3.42 (br.
s, 1 H, B12–H), 3.28 (br. s, 1 H, B9–H), 3.17 [br. s, 2 H, B(3,6)–
H], 3.13 [br. s, 2 H, B(8,10)–H], 2.97 [br. s, 2 H, B(7,11)–H], 2.89
[br. s, 2 H, B(4,5)–H] ppm. 13C NMR (151 MHz, C6D6): δ = 131.73
(C–Ar), 131.49 (C–Ar), 130.34 (C–Ar), 128.68 (C–Ar), 86.29 (C–
carborane), 85.98 (C–carborane), 83.65 (Fc), 71.77 (Fc), 71.04 (Fc),
69.02 (Fc) ppm. 11B NMR (128 MHz, C6D6, BF3·OEt2): δ = –0.97
(d, JB,H = 110 Hz, 1 B, B12), –1.78 (d, JB,H = 114 Hz, 1 B, B9),
–7.86 [d, JB,H = 142 Hz, 4 B, B(8,10; 7,11)], –9.29 [d, JB,H
=
110 Hz, B(3,6)], –10.02 [d, JB,H = 110 Hz, 2 B, B(4,5)] ppm.
HRMS (EI) calcd. for C18H2410B211B8Fe: 404.2231; found
404.2227. MS (EI): m/z (%) = 404.2 (100) [M+], 278.2 (5), 200.1
(10), 121.2 (20). C18H24B10Fe (406.22): calcd. C 53.48, H 5.98, Fe
found C 53.83, H 5.07, Fe 20.14. IR (KBr): ν = 2636, 2600, 2583,
˜
2572, 2234, 1106, 1046, 1022, 829, 821, 506, 486 cm–1. Rf (5:1 hex-
ane/CH2Cl2) = 0.3.
13.81; found C 53.63, H 5.81, Fe 13.56. IR (KBr): ν = 2642, 2600,
˜
2582, 2561, 1416, 1281, 1045, 1003, 830 cm–1. Rf (2:1 hexane/
1-Ferrocenyl-2-acetyl-1,2-dicarba-closo-dodecaborane (2g): 4-Ferro-
CHCl3) = 0.4.
cenylbut-3-yn-2-one (108 mg, 0.4 mmol), 6,9-(Me2S)2-B10H12
Eur. J. Inorg. Chem. 2013, 2789–2798
2796
© 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim